Using tubule‐specific deletion of Mydgf mice, we demonstrated that Mydgf deficiency promoted tubular injury by disrupting mitochondrial homeostasis in mice with various CKD models, suggesting that MYDGF is an attractive therapeutic target for CKD. This evidence concerns the gene MYDGF and chronic kidney disease.